<DOC>
	<DOCNO>NCT00171782</DOCNO>
	<brief_summary>A study evaluate efficacy valsartan+chydochlorothiazide patient stage 2 hypertension cardiovascular risk factor .</brief_summary>
	<brief_title>Hypertension Cardiovascular Risk Factors</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Patients give consent Men woman 18 80 year age Patients hypertension ( systolic &gt; 159 mm , diastolic &gt; 100 mm ) Patients meet laboratory criterion Pregnant woman Women use approved contraception method Secondary hypertension Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>HYPERTENSION</keyword>
	<keyword>VALSARTAN</keyword>
	<keyword>VALSARTAN AND HYDROCHLOROTHIAZIDE</keyword>
	<keyword>RISK FACTORS</keyword>
</DOC>